期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Rationale and Role of High Loading Dose Clopidogrel in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
1
作者 Sam T. Mathew Gayathri Devi S +1 位作者 Prasanth V. V vinod b 《Pharmacology & Pharmacy》 2012年第4期481-484,共4页
Antiplatelet therapy, which reduces platelet activation and aggregation, is the corner stone of treatment for patients undergoing percutaneous coronary intervention (PCI). Clopidogrel is an established oral antiplatel... Antiplatelet therapy, which reduces platelet activation and aggregation, is the corner stone of treatment for patients undergoing percutaneous coronary intervention (PCI). Clopidogrel is an established oral antiplatelet medication of thienopyridine class, which inhibits blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease. Many studies have revealed that high loading dose clopidogrel in patients undergoing PCI. This review article investigates the rationale and role of high loading dose clopidogrel in patients undergoing PCI. 展开更多
关键词 CLOPIDOGREL ANTIPLATELET Therapy PERCUTANEOUS CORONARY Intervention
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部